# Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease

> **NCT03791775** · PHASE2 · COMPLETED · sponsor: **Societa Italiana di Chirurgia ColoRettale** · enrollment: 183 (actual)

## Conditions studied

- Second-degree Hemorrhoids

## Interventions

- **DRUG:** Polidocanol foam (Atossisclerol® 3%)

## Key facts

- **NCT ID:** NCT03791775
- **Lead sponsor:** Societa Italiana di Chirurgia ColoRettale
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-02
- **Primary completion:** 2019-06-02
- **Final completion:** 2020-06-02
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2021-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791775, "Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03791775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*